ACT 335827

CAS: 1354039-86-3

Ref. 3D-EEC03986

Produktinformation

• Name: ACT 335827

Beschreibung

ACT 335827 is a drug that is effective in the treatment of hypertension. It has a pyrazole ring, which is metabolized to form fatty acids, and it targets the pressor pathway by inhibiting phosphodiesterase-3. ACT 335827 also interacts with the template molecule, hydrogen bond, and constant region of the protein. The pharmacological effects are mediated through pharmacological agents that alter physiological processes. Almorexant is one such agent, which inhibits orexin receptors in the brain to induce sleepiness.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 518.64 g/mol
• Formel: C₃₁H₃₈N₂O₅
• Reinheit: Min. 95%